CHAIRMAN KASS:  Good morning, and welcome to the second day of the 7th meeting of the President's Council on Bioethics, and welcome especially to our fellow citizens, and members of the public. 

I would like to introduce first a new member of our staff, Carter Snead, whom I mentioned yesterday.  Carter will be joining us in a couple of weeks.  He is a lawyer, who has been liberated from Ropes and Gray to come spend some time with us, and we will be working on the things that we are speaking about this morning. 

After yesterday's discussion of topics that have to do with extra therapeutic -- possible extra therapeutic uses of biomedical technology, we return this morning to another subject that has occupied us really for -- since the beginning, namely the question of the regulation of biomedical technologies.

And we are very fortunate this morning to have not just one, but two distinguished visitors from the mother country, the nation that has in fact taken the lead in the regulation of biomedical technology, and we stand to learn a great deal from their contributions.

I would like to welcome Baroness Helena Kennedy, who is the Chair of the Human Genetics Commission, and Ms. Suzi Leather, who is the Chair of the Human Fertilization and Embryology Authority. 

And we will have presentations in that order, with a break in between. And without further adieu, let me simply ask Baroness Kennedy to begin.  Thank you very much both for being here.